Company intelligence / Profile preview

Koa Health

London, England, United Kingdomkoahealth.com ↗

Ownership: Private
Development stage: Other

Overview

Koa Health’s digital mental health solutions have demonstrated significant benefits in randomized controlled trials. Their flagship app, Koa Foundations, has shown measurable improvements in user wellbeing within two to four weeks of use. The company continues to conduct pivotal clinical trials toward FDA clearance for its digital therapeutics targeting depression, anxiety, PTSD, BDD, and OCD.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (digital therapeutics)Device (mobile and web-based apps)AI-driven digital intervention
Industry: Digital Health Medical Devices

Partnerships

Collaborations with Massachusetts General Hospital (#1 US-ranked hospital for psychiatry & psychology)Birmingham and Solihull Mental Health NHS Foundation TrustEducation FirstO2

Beyond the preview

Go deeper on Koa Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Koa Health.

Explore the full profile